The Singleton Schreiber Law Firm is seeking individuals who developed potentially life-altering brain tumors as a result of using a popular birth control injection. Singleton Schreiber says the ...
If you have used Depo-Provera, you may have heard recent reports suggesting a potential link between this birth control injection and an increased risk of brain tumors known as meningiomas. It is ...
Recent scientific research has uncovered a significant association between the long-term use of Depo-Provera, a widely used injectable contraceptive, and the development of meningiomas, tumors ...
-- Global pharmaceutical company Pfizer Inc. (NYSE: PFE), manufacturer of contraceptive injection Depo-Provera (DMPA), is facing a Multidistrict Litigation (MDL No. 3140) in the USA being brought on ...
A study published on 29 June 2025 in international peer reviewed medical journal Expert Opinion on Drug Safety by Frey et al. has found that use of Pfizer’s Depo-Provera (DMPA) for more than one year ...
The MarketWatch News Department was not involved in the creation of this content. The number of lawsuits filed has tripled to over 1300 since May New US peer-reviewed study adds to body of research ...
Lawsuits allege that the defendants manufactured, promoted, and sold the prescription drug Depo-Provera without adequately warning of its connection to the development of meningiomas, a type of brain ...
The motion cites 22 cases, most in California, filed against brand manufacturer Pfizer Inc. and authorized generic providers. The motion says most of the plaintiffs will be in Massachusetts or ...
U.S. District Judge M. Casey Rodgers of the Northern District of Florida is overseeing more than 400 lawsuits alleging that Depo-Provera, an injectable birth control, has caused non-malignant brain ...
The decision comes as Pfizer faces lawsuits from more than 1000 women who say the company knew about the risks and didn’t warn them. The agency signed off last week on a label update for 2 versions of ...
Hosted on MSN
Depo Provera brain tumor warning: Why the FDA changed the label and what it means for users
The FDA has approved a critical label change for Pfizer's widely used Depo-Provera birth control injection, adding a warning about the risk of meningioma—a typically non-cancerous but potentially ...
A popular injectable birth control, Depo-Provera (medroxyprogesterone acetate) — also sold as Depo-SubQ Provera 104 — has long been favored for its 99% effectiveness and ease of use compared to daily ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results